Kerry’s Blind Trust Has 20/20 Vision

Media Buys False “Blind Trust” Excuse for Suspicious Kerry Stock Trades

With details now erupting on Capitol Hill about Sen. John Kerry’s (D-MA) questionable investments, a curious question lingers: why did it take a Tallahassee-based think tank wonk to uncover a former presidential candidate’s aggressive trading of pharmaceutical stock during both the 2009 Obamacare debate and the 2003 prescription drug benefit plan debate?  Continue reading on

About Alan Berkelhammer

Opinions are my own and are not necessarily those of any organization or group.
This entry was posted in Legislative Branch, Major News Items and tagged , , , . Bookmark the permalink.

Leave a Reply